EZH2 cooperates with gain‐of‐function p53 mutants to promote cancer growth and metastasis

In light of the increasing number of identified cancer‐driven gain‐of‐function (GOF) mutants of p53, it is important to define a common mechanism to systematically target several mutants, rather than developing strategies tailored to inhibit each mutant individually. Here, using RNA immunoprecipitat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:EMBO J
Hoofdauteurs: Zhao, Yu, Ding, Liya, Wang, Dejie, Ye, Zhenqing, He, Yundong, Ma, Linlin, Zhu, Runzhi, Pan, Yunqian, Wu, Qiang, Pang, Kun, Hou, Xiaonan, Weroha, Saravut J, Han, Conghui, Coleman, Roger, Coleman, Ilsa, Karnes, R Jeffery, Zhang, Jun, Nelson, Peter S, Wang, Liguo, Huang, Haojie
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2019
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6396169/
https://ncbi.nlm.nih.gov/pubmed/30723117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embj.201899599
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items